Cyclacel Pharmaceuticals, Inc. (CYCC)

NASDAQ: CYCC · Real-Time Price · USD

2.750

-0.840 (-23.40%)

At close: May 13, 2025, 4:00 PM

2.880

+0.130 (4.73%)

Pre-market: May 14, 2025, 6:22 AM EDT

Cyclacel Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-11.21	-22.56	-21.2	-18.46	-8.45	Upgrade
Depreciation & Amortization	0.01	0.03	0.03	0.04	0.02	Upgrade
Stock-Based Compensation	0.59	1.47	1.51	1.16	0.43	Upgrade
Other Operating Activities	-0.04	-0.07	0.04	0.17	-0.09	Upgrade
Change in Accounts Payable	-1.81	0.3	2.58	3.03	0.03	Upgrade
Change in Other Net Operating Assets	4.47	4.71	-3.78	-4.48	0.12	Upgrade
Operating Cash Flow	-7.99	-16.11	-20.83	-18.54	-7.93	Upgrade
Capital Expenditures	-	-0.01	-0.01	-0.03	-0.1	Upgrade
Investing Cash Flow	-	-0.01	-0.01	-0.03	-0.1	Upgrade
Issuance of Common Stock	7.82	1.05	3.2	21.94	25.99	Upgrade
Preferred Dividends Paid	-	-0.2	-0.2	-0.2	-0.2	Upgrade
Dividends Paid	-	-0.2	-0.2	-0.2	-0.2	Upgrade
Other Financing Activities	-	-	-	-	-0.06	Upgrade
Financing Cash Flow	7.82	0.85	3	21.74	29.5	Upgrade
Foreign Exchange Rate Adjustments	-0.07	0.3	-0.38	-0.02	0.05	Upgrade
Net Cash Flow	-0.24	-14.97	-18.21	3.15	21.52	Upgrade
Free Cash Flow	-7.99	-16.12	-20.83	-18.57	-8.03	Upgrade
Free Cash Flow Margin	-18581.40%	-3837.62%	-	-	-	Upgrade
Free Cash Flow Per Share	-23.87	-303.11	-444.23	-499.22	-530.42	Upgrade
Cash Income Tax Paid	-3.71	-4.84	-3.31	-1.36	-1.29	Upgrade
Levered Free Cash Flow	-5.27	-11.76	-15.34	-12.21	-6.16	Upgrade
Unlevered Free Cash Flow	-5.27	-11.76	-15.34	-12.21	-6.16	Upgrade
Change in Net Working Capital	-1.64	-2.65	-0.42	-0.61	-0.14	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q